搜尋結果
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 2 日前, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales ... ...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 1 日前, opens new tab lifted its annual earnings forecast on Wednesday and reported a first-quarter ...
Novo Trades at Hefty Discount to Lilly Even After 350% Rally
Bloomberg· 9 小時前Novo Nordisk A/S’s more than 350% rally over the past four years may have further ...
US Senators Introduce Bill To Legalize Marijuana
Forbes· 17 小時前A group of 18 Democratic Senators this week reintroduced a bill to legalize marijuana ... ...
Amgen investors await weight-loss drug data
Reuters· 1 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
Israel issues Sweden Eurovision travel warning amid planned protests
Reuters· 9 小時前Sweden has promised a dazzling show from May 7-11, but it will take place amid demonstrations ...
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 3 日前Eli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, ...
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, ...
CNBC· 2 日前Lilly on Tuesday reported first-quarter adjusted profit that topped Wall Street's expectations and hiked ...
The Forgotten Stock Advice That Delivers 170%+ Payout Growth
Forbes· 2 日前One of the best ways to grab a dividend payer set to surge is a ...
Forbes Daily: Why ‘Bitcoin Jesus’ Could Be Extradited To The U.S.
Forbes· 17 小時前What if your pharmacist could prescribe your medications? In select cases at pharmacy giants ...